CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia

Clinical trial NCT05168748 · WITHDRAWN

Trial details

NCT number: NCT05168748
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2023-01-24
Primary completion: 2026-08-13
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.